Russia Prepares $10 COVID-19 Vaccine For International Launch

Aims To Compete With Pfizer On Efficacy, Undercut On Price

Sputnik
Russia has just announced a second interim readout, edging its efficacy claims to over 95%. • Source: RDIF
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip